Introduction
The undifferentiated cell state in vertebrate embryogenesis and the maintenance of pluripotency in embryonic stem (ES) cells is characterized by the expression of specific transcription factors, which are silenced during differentiation. A major component of the gene regulatory network controlling pluripotency is Oct3/4, a Pou5f1 gene expressed in the mammalian blastocyst and in blastocyst-derived embryonic stem cells (Nichols et al., 1998) . Importantly, homologues of the Oct3/4 gene have been identified in non-mammalian vertebrates, like chicken, frog and fish (Lavial et al., 2007; Hinkley et al., 1992; Morrison and Brickman, 2006; Cao et al., 2006 Cao et al., , 2007 Burgess et al., 2002) , indicating phylogenetic conservation of basic pluripotency-preserving mechanisms across vertebrate species.
Over the last few years, a number of genes exhibiting expression patterns closely resembling Oct3/4 have been identified in mammals, and thus been termed developmental pluripotency associated (Dppa) genes (Bortvin et al., 2003) . Notably, Dppa genes are not necessarily related by sequence similarity or the presence of specific protein motifs, but have 0925-4773/$ -see front matter Ó 2009 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2009.09.007 in common the expression in pluripotent cells and a downregulation at the beginning of differentiation, similar to the pluripotency markers Oct3/4, Sox2 and nanog (Boiani and Schö ler, 2005) . Mouse Dppa1 is expressed in ES cells and is upregulated at the morula-to-blastocyst transition (Bortvin et al., 2003) . The protein is similar to Kim-1 in that it contains a single transmembrane domain (Ichimura et al., 1998 ). Dppa2, originally described as embryo/cancer sequence A (ECSA: Monk and Holding, 2001) , and Dppa4 are highly homologous and located next to each other in both the human and the mouse genomes (Maldonado-Saldivia et al., 2007) , most likely indicating that they have originated during evolution from a common ancestor by gene duplication. Both proteins share a putative DNA-binding motif named SAP domain (Scaffold-attachment factor A/B, Acinus and PIAS (protein inhibitor of activated STATs)). Such a domain has been identified in several proteins thought to be involved in chromosomal organization as well as in RNA modification (Aravind and Koonin, 2000) . SAP domains contain a bipartite distribution of strongly conserved hydrophobic, polar und bulky amino acids, separated by a region that contains an invariant glycine. Moreover, Dppa2 and Dppa4 show a similar but not identical expression pattern in pre-implantation mouse embryos and cells of the germ line (Bortvin et al., 2003; Maldonado-Saldivia et al., 2007) . Overexpression of Dppa4 in ES cells has been reported to inhibit differentiation into mesodermal cell lineages and to cause cell death, while the knockdown by shRNA appears to induce cell differentiation into a primitive ectodermal lineage, indicated by an increased expression of FGF5. In contrast, no effect has been detected upon overexpression of Dppa2 in ES cell cultures (Masaki et al., 2007) .
Dppa3, also known as stella or PGC7, was first isolated from primordial germ cells (Saitou et al., 2002; Sato et al., 2002) . The protein has a SAP domain as well, but contains in addition a splicing factor motif-like structure (Payer et al., 2003; Bortvin et al., 2004 ) that is not found in Dppa2 and Dppa4 proteins. Dppa3 deficiency in mice results in a severe reduction of female fertility (Payer et al., 2003) . Recent studies revealed that Dppa3 protects the maternal genome from demethylation (Nakamura et al., 2007) implicating that at least some SAP domain-containing proteins may participate in epigenetic processes. Of note, Dppa3 shares the same genomic locus with nanog, FOXJ2 and GDF3, a region known to be a hotspot for structural chromosomal changes associated with teratocarcinoma formation in humans (Clark et al., 2004) . Dppa5, which is also known as retinoic acid down regulated protein Ph34 or ECAT2 (Siomi et al., 1994) , belongs to the KHDC1/ECAT1/OOEP/Dppa5 family. These proteins contain a KH domain that is essential for RNA binding. The corresponding genes are exclusively expressed in oocytes and embryonic stem cells. Interestingly, they are found only in eutherian mammals being absent from marsupial and nonmammalian genomes (Pierre et al., 2007) . Since Dppa5 À/À mice show normal development and are fertile, the role of Dppa5 remains to be elucidated (Amano et al., 2006) . So far, our relatively limited knowledge about physiological functions of Dppa genes has been obtained from the study of mammalian cells. We therefore wished to know whether such genes also exist in other vertebrates and which functions they might serve. In the present study we have identified a gene, XDppa2/4, in Xenopus laevis and Xenopus tropicalis, which shows similarities to mammalian Dppa2 and Dppa4. Like human and mouse counterparts, the Xenopus gene also encodes a SAP domain and, additionally, a conserved C-terminal region. Analyses of its temporal and spatial expression patterns revealed that XDppa2/4 is maternally transcribed. The transcripts are localised within the animal half of cleavage stage embryos and start to diminish at the beginning of midblastula transition. At the end of neurulation, XDppa2/4 transcripts are no longer detected. In loss of function analyses we demonstrate that XDppa2/4 is required for correct formation and closure of the blastopore as well as for formation of the neural fold. XDppa2/4-depleted embryos die after completion of neurulation. The XDppa2/4 gain of function phenotype was also characterized by a failure of blastopore closure, a phenotype strikingly similar to that observed after injection of mDppa2 and mDppa4. Ectopic expression of XDppa2/4 and mDppa4 triggers apoptosis at the gastrula stage by increasing the activities of effector caspases 3/7. Elevated rates of apoptosis were also found at later developmental stages in loss of function studies. Morpholino (MO)-mediated loss of XDppa2/4 function during gastrulation could be rescued by injection of mammalian Dppa2, indicating conserved functions. However, subsequent death of XDppaMO injected embryos was neither prevented by mDppa2 nor by mDppa4 injection. An analysis of XDppa2/4 mutants lacking the SAP and/or the C-terminal domain revealed that the gain and loss of function effects during gastrulation are mediated by the conserved C-terminal region and do not depend upon nuclear localization. However, survival of embryos at later stages of development is strictly dependent upon the SAP domain, even when XDppa2/4 transcripts disappear at the end of gastrulation. Since the SAP domain is required for association of XDppa2/4 to chromatin, we suppose a role of XDppa2/4 in epigenetic programming events as has recently been suggested for Dppa3 (Nakamura et al., 2007) .
Results

Identification of the XDppa2/4 gene
To check for the existence of a Dppa-like gene in Xenopus we have performed a Blast search with mouse and human Dppa cDNA and protein sequences against Xenopus sequence data libraries. Using the mDppa4 protein sequence as query resulted in identification of similar sequences in X. laevis (Accession Number NP_001089568) and X. tropicalis (Accession Number AAI61173). When these sequences were blasted in turn against mammalian data libraries, the highest homology was found for mammalian Dppa2. We therefore designated the newly identified Xenopus sequences as XDppa2/4.
An alignment between the X. laevis and tropicalis XDppa2/4 amino acid sequences with mouse or human Dppa2 and Dppa4 (Fig. 1A) revealed an overall identity between the mammalian and amphibian proteins of almost 25%. For comparison, the identity between mDppa2 and hDppa2 or mDppa4 and hDppa4 amounts to 44% or 52%, respectively, and to 32% when comparing mDppa2 and mDppa4 (MaldonadoSaldivia et al., 2007) . Noteworthy, both mammalian Dppa2 and Dppa4 share with the Xenopus sequences the characteristic SAP domain ( Fig. 1A and B) . Moreover, the other conserved motif of mammalian Dppa2 and Dppa4 located at the C-terminus (Maldonado-Saldivia et al., 2007) is also found in XDppa2/4. This Dppa2/4 conserved region (abbreviated DCR) and the SAP domain show a high degree of amino acid sequence similarity between all Dppa2 and Dppa4 species identified so far, notably including XDppa2/4 (Fig. 1B) , which thus can be classified as a true homologue of mammalian Dppa2/4 proteins. There are several proteins containing either the SAP domain or the DCR. However, concomitant presence of both modules was not found in any protein, other than Dppa2 and Dppa4 (Fig. 1B) . While the human and mouse Dppa proteins are composed of approximately 300 amino acids, the XDppa2/4 proteins in X. laevis and X. tropicalis contain just 240 and 241 amino acids, respectively.
Additional database analysis revealed a putative Dppa2/4 homologue on chromosome 4 of the marsupial short-tail opossum (Ensembl: ENSMODP00000022542), a finding further strengthened by ESTs EC346351 and EC304522 isolated from the Australian brush tail possum. Furthermore, a Dppa2/4-like gene was identified in the reptile genome of Anolis carolinensis (ENSACAP00000003902) along with corresponding ovary-derived ESTs FG764357 and FG91940. All deduced protein sequences contain a DCR and a SAP domain. In conclusion, Dppa2/4-like genes are not confined to higher mammals, but also present in other vertebrates. A phylogenetic tree established from the results of blast analyses for human, murine, opossum, Anolis and Xenopus Dppa2/4 proteins is shown in Fig. 1C . In the Ensembl database (Xenopus tropicalis genome assembly; Version 4.1), the XDppa2/4 gene is located in scaffold 673 and predicted to contain eight coding exons (Fig. 1D) . Blasting the X. tropicalis genome with the XDppa2/4 sequence we were unable to identify any additional homologous genes encoding SAP and DCR containing proteins.
2.2.
XDppa2/4 exhibits a pluripotency associated expression pattern
Restricted expression to pluripotent cells and shut-down of gene activity concomitant with differentiation are a hallmark of most pluripotency factors known so far. The temporal expression pattern of XDppa2/4 was analyzed by real time RT-PCR using RNA extracted from different developmental stages ( Fig. 2A) . XDppa2/4 is maternally transcribed and transcripts are detected at high levels during early cleavage stages. However, the amount of transcripts is rapidly and continuously decreasing after midblastula transition. During neurulation, the signal can no longer be detected. We have also analyzed the relative expression of transcripts in adult tissues by real time RT-PCR (Fig. 2B ). Very high expression was detected in ovaries and weak expression was found in gut, whilst nearly no expression was found in brain, eye, heart, liver and testis.
Whole mount in situ hybridization was used to analyze the localization of transcripts during early embryonic development (Fig. 2C ). XDppa2/4 transcripts are enriched in the animal part of early cleavage stage embryos. During blastula (stages 7.5-9) and gastrula (stages 10-12) this region corresponds to future ectodermal and mesodermal tissues. In early neurulating embryos, transcripts are restricted to the neuroectoderm, whereas during neural fold closure (stages 16-18) transcripts are no longer detectable within the embryo, neither by real time RT-PCR nor by whole mount in situ hybridization. In summary, XDppa2/4 behaves like other pluripotency associated genes, showing a maternal contribution and a drastic decrease of gene activity during gastrulation, when the tissue differentiation program is initiated.
2.3.
Knockdown of XDppa2/4 leads to gastrulation defects culminating in total lack of neurulation For loss of function studies, we designed an antisense morpholino oligonucleotide (Fig. S1A ) and examined its functional efficiency by using an in vitro transcription/translation assay. We observed a loss of XDppa2/4 protein synthesis after addition of XDppa2/4 morpholino (XDppaMO), but no reduction when a standard control morpholino (ctrlMO) was added (Fig. S1B ). To further analyze the specificity of XDppaMO, we mutated the morpholino binding sequence in XDppa2/4 by seven silent mutations (Fig. S1A ). Translation of this mutated sequence, mut-XDppa2/4, in the in vitro system was not extinguished by XDppaMO (Fig. S1B ). The morpholino efficiency was also tested in vivo using XDppa2/4 RNA, which was tagged at the C-terminus with enhanced green fluorescent protein (EGFP), followed by immunoblotting to monitor protein expression (Fig. S1C) . In contrast to the lack of translation by co-injection of XDppa2/4-EGFP RNA and XDppaMO, injection of mutated XDppa2/4-EGFP (mut-XDppa2/4-EGFP) together with XDppaMO did not show any effect on translation efficiency. Likewise, co-injection of XDppa2/4-EGFP RNA and ctrlMO did not alter protein expression.
To analyze the phenotype obtained after loss of XDppa2/4 function we injected a total amount of 50 ng XDppaMO into both blastomeres of 2-cell stage embryos (Fig. 3A) . Almost all injected embryos (228/240) showed a wide-open blastopore at stage 11 as compared to uninjected embryos (1/240) or embryos injected with 50 ng ctrlMO (4/237). While neural fold closure in normal or ctrlMO injected embryos became apparent at stage 18, 78% (187/240) of the XDppaMO injected embryos failed to close their blastopore. This lack of normal gastrulation movements leads to a total loss of neural fold formation. At the time point, when normal embryos had completed neurulation, most of XDppaMO injected embryos started to die and to disintegrate. To demonstrate the specificity of the XDppa2/4 knockdown phenotype, we also co-injected the XDppaMO together with mut-XDppa2/4 RNA (Fig. 3A) . 86% (129/150) of the injected embryos were completely rescued, which means, these embryos exhibited normal gastrulation and neurulation movements. 70% (107/150) of these embryos developed normally and reached tailbud stage.
2.4.
XDppa2/4 overexpression phenocopies mDppa2 and mDppa4 overexpression
To investigate the XDppa2/4 gain of function phenotype and to determine the functional relationship between XDppa2/4 and mammalian Dppa2 or Dppa4, we have injected varying amounts of XDppa2/4, mDppa2 or mDppa4 RNA into the equatorial region of both blastomeres at the 2-cell stage. These gain of function experiments revealed dose dependent defects during gastrulation. Fig. 3B shows the results obtained after injection of 400 pg XDppa2/4, 800 pg mDppa2 or 100 pg mDppa4 RNA. More than 95% (382/400) of XDppa2/4 injected embryos displayed an obvious developmental delay, represented by a wide-open blastopore, when controls had reached stage 11.5, and a disturbed closure of the blastopore in more than 80% (325/400) of embryos, when controls had reached stage 17. In contrast to the knockdown phenotype, neural plate formation took place and injected embryos even exhibited both an anterior/posterior and a dorsal/ventral axis. However, they showed an open neural fold, reduced axis formation as well as malformed head and tail structures.
Remarkably, overexpression of mouse Dppa2 or Dppa4 revealed similar phenotypes including failure of blastopore closure, open neural fold and axis reduction. However, mDppa2 and mDppa4 RNAs differed in their efficiencies to generate this phenotype. 800 pg of mDppa2, but only 100 pg of mDppa4 RNA were necessary to phenocopy the effect of 400 pg of XDppa2/4. These differences probably reflect different translational efficiencies as demonstrated by in vitro translation assays (data not shown).
2.5.
Analysis of gene expression after gain and loss of XDppa2/4 function To explore the molecular events underlying the phenotypes observed by loss or gain of function, as well as to obtain more information about functional homologies between Xenopus Dppa2/4 and mouse Dppa2 and Dppa4, we performed whole mount in situ hybridization of injected embryos for selected marker genes (Fig. 4) . Embryos were injected as previously described at the 2-cell stage and RNA was analysed at stage 11. XDppa2/4 gain of function embryos showed reduced staining for Xbra, especially at the ventrolateral side, as compared to uninjected control embryos. A similar result was obtained with embryos injected with mDppa4 and mDppa2. XDppa2/4 loss of function embryos showed only a weak Xbra staining. The ventral marker BMP4 and the ventrolateral marker MyoD were strongly suppressed by overexpression of XDppa2/4, mDppa2 and mDppa4. However, ventral expression of BMP4 was enhanced by XDppaMO injection, whereas MyoD was also diminished by loss of function. Embryos analysed for Gsc expression, a marker for dorsal mesoderm, normally show staining at the dorsal lip and invaginated mesoderm. Injections of XDppa2/4, mDppa2 and mDppa4 RNA resulted in a stronger and more intensive staining at the blastopore lip. Gsc expression in XDppaMO injected embryos was restricted to the dorsal lip, indicating inhibition of embryo invagination and cell migration. Normally expressed at the dorsal animal half, XSox2 was strongly reduced by XDppa2/4, mDppa2 and mDppa4 RNA and even completely absent in XDppa2/4 loss of function embryos. All injected Dppas, especially XDppa2/4
Fig. 4 -Whole mount in situ hybridization of gain and loss of function embryos. Embryos were injected with XDppa2/4, mDppa2, mDppa4 RNA or XDppaMO into both blastomeres at 2-cell stage. Whole mount in situ hybridization was performed at stage 11 for Xbra, BMP4, MyoD, Gsc, XSox2, Xema and XSox17a. Uninjected embryos or embryos injected with ctrlMO show the expected wild type expression pattern of marker genes at stage 11. Orientation of embryos is given. For the vegetal view the dorsal side is always located at top and for the lateral view the dorsal side is located at the left side.
and mDppa4 induced higher expression of Xema, a Fox gene involved in the suppression of mesendoderm within the ectoderm (Suri et al., 2005; Mir et al., 2007) . Also, the XDppaMO injected embryos showed a slight increase of signal intensity for Xema. XSox17a expression, which is normally observed in the endoderm, was strongly disturbed by gain of XDppa2/4 function. However, no change in the XSox17a expression pattern was observed after injection of XDppaMO.
To gain a more comprehensive overview on changes in gene expression, we performed real time RT-PCR analyses after loss (Fig. S2A ) and gain of function (Fig. S2B) . Xbra was slightly decreased in XDppaMO injected embryos as well as in XDppa2/4, mDppa2 or mDppa4 gain of function experiments. Injection of XDppaMO led to an upregulation of BMP4 and XVent1 suggesting a ventralizing effect. Conversely, XDppa2/ 4 and mDppa2 or mDppa4 RNA injections resulted in downregulation of BMP4 and XVent1. Gsc was slightly decreased upon loss of function and increased by gain of function. Both, loss and gain of function experiments led to an upregulation of the VegT target genes Xnr5 and Xnr6, as well as of the b-catenin target genes Siamois and Xnr3. While the ectodermal marker Ectodermin was unaffected by loss of function, in gain of function both Ectodermin as well as Xema were increased. The neuroectodermal markers XSox3 and GemininH were increased by both, loss and gain of functions. The neural markers Ncam and N-tubulin and the epidermal marker grainyhead like 2 (grhl2) showed an increase after injection of XDppaMO, but were decreased by gain of function. The early endodermal marker XSox17a was not affected by XDppaMO injection, but slightly decreased by gain of function. Also, the pluripotency marker Oct25 was barely affected by both, gain and loss of function. In contrast, overexpression of Oct25 caused a twofold increase of XDppa2/4 transcripts (data not shown). While mouse and human Dppa4 have indeed been identified as targets of the Oct3/4-Sox2 complex (Boyer et al., 2005; Chakravarthy et al., 2008) , a similar type of regulation for XDppa2/4 by a putative Xenopus POU-V factor/XSox2 complex remains to be elucidated.
In summary, the loss of XDppa2/4 function seems to be characterized by an increase of Xnrs and ventral mesodermal markers coupled with an increase of neuroectodermal, neural and epidermal markers. However, gain of function also leads to an increase of mesendodermal inducers as well as of early neuroectodermal markers, thereby preventing a simple molecular interpretation of the gain and loss of function phenotypes. Noteworthy, there are some quantitative but no real qualitative differences in the effects mediated by XDppa2/4 as compared to mouse Dppa2 and Dppa4.
2.6.
Injection of mDppa2 rescues the early XDppa2/4 loss of function phenotype
Most of the results presented so far demonstrate that mDppa2, mDppa4 and XDppa2/4 have similar effects in gain of function studies including their regulatory potential on target genes. However, it is not clear whether the function of XDppa2/4 can really be replaced by the mouse homologues. We therefore asked, whether injection of mDppa2 and mDppa4 RNA alone or in combination would rescue the XDppa2/4 loss of function phenotype.
A dose of 50 ng XDppaMO was co-injected with varying amounts of mDppa2, mDppa4 RNA or with combinations of both RNAs. While mDppa4 failed to restore normal development, we observed a normal closure of the blastopore in about 68% (102/150) of embryos co-injected with 600 pg mDppa2 RNA. Moreover, neurulation was demonstrated by neural fold formation at stage 17 (Fig. 5) . While whole mount in situ hybridizations for the mesodermal marker Xbra, the axial marker Chordin and the neuroectodermal marker XSox2 showed reduced or delocalised staining in XDppaMO injected embryos, staining was restored to almost normal levels in embryos co-injected with mDppa2, thereby demonstrating the rescue of axis formation and neurulation. However, death of embryos before the tailbud stage as a late consequence of XDppaMO injection (Fig. 3A) could neither be prevented by injection of mDppa2 nor mDppa4 RNA nor by varying mixtures of mDppa2 and mDppa4 transcripts (data not shown). Based upon these observations, we conclude that mammalian Dppa2 can functionally replace XDppa2/4 during the gastrulation and neurulation processes. However, XDppa2/4 is required for additional functions, which cannot be substituted by mDppa4 or mDppa2.
Functional analyses of distinct XDppa2/4 domains
For a more detailed analysis of the SAP and DCR domains we prepared a series of deletion constructs (Fig. 6A) . Mutant transcripts derived from these constructs were injected and the phenotypes monitored at stage 11.5 (Fig. 6B) . Unexpectedly, overexpression of DSAP RNA resulted in disrupted blastopore formation, which had also been observed after injection of wild type XDppa2/4 RNA. In contrast, embryos injected with RNAs encoding DDCR, DSAPDDCR and the XDppa2/4 aa1-65 deletion mutants, all lacking the DCR domain, developed normally, while injection of transcripts derived from mutant constructs DN-term or aa66-240, which still encode the DCR domain, gave rise to severe gastrulation defects. Moreover, RT-PCR analysis of total RNA from embryos injected with DSAP RNA revealed that expression of analyzed marker genes resembled the pattern observed in embryos overexpressing wild type RNA (data not shown). These observations suggest that the DCR domain but not the SAP domain is responsible for the phenotypic effects observed after XDppa2/4 overexpression. However, neither injection of DCR alone nor of SAP + L + DCR was sufficient to induce a failure of gastrulation. These results indicate that in addition to the DCR domain at least part of the C-terminal region of XDppa2/4 is required for generating phenotypic defects in gastrulation.
We next asked whether the SAP domain plays an essential role in restoring loss of function phenotypes caused by XDppaMO. Therefore, rescue experiments with mut-XDppa2/4 as well as mut-DSAP constructs, in which the XDppaMO binding site had been mutated by seven silent mutations, were performed. It turned out that MO-induced phenotypic defects were prevented by co-injection of mut-XDppa2/4 as well as mut-DSAP RNA (Fig. 6C ). All defects in blastopore closure and neural fold formation were completely rescued. However, unlike in case of wild type XDppa2/4 (mut-XDppa2/4), embryos co-injected with mut-DSAP died after the end of neurulation.
These results suggest that non-availability of the SAP domain alone does not account for the loss of function phenotype observed during gastrulation while its presence is clearly essential for survival at later stages.
Subcellular localization of XDppa2/4 deletion mutants
To test the subcellular localization of XDppa2/4 as well as the XDppa2/4 deletion mutants (Fig. 6A) we transiently transfected expression plasmids encoding XDppa2/4 proteins fused to EGFP into HeLa cells (Fig. 7A and summarized in Fig. 7C ). EGFP alone was localised ubiquitously in the cells. In contrast to EGFP, XDppa2/4-EGFP showed nuclear localization together with a specific subnuclear distribution. This specific subnuclear localization was characterized as chromatin association by co-localization with histone H2B (Fig. 7B) . Deletion of the SAP domain resulted in a clear decrease of nuclear staining. Most of the XDppa2/4 DSAP protein localised to the cytoplasm suggesting that the SAP domain plays an important role in nuclear trafficking and chromatin association. In contrast, deletion of the DCR domain showed again a nuclear staining being undistinguishable from the wild type protein. Interestingly, DSAPDDCR representing deletions of both the SAP domain and the DCR domain, localised to the nucleus but chromatin association was lost (Fig. 7B) . The DCR domain alone fused to EGFP revealed an ubiquitous localization, similar to EGFP. SAP + L + DCR and aa1-65 mutants again localised to the nucleus, whereas the mutant aa66-240 containing part of the linker region, the DCR domain and the C-terminal part localised preferentially to the cytoplasm. The 19 N-terminal aa do not account for nuclear localization, because the DN-term mutant also showed nuclear localization. Taken together, our results suggest that the SAP domain is not only essential for nuclear import but also for chromatin association. The DCR domain does not contain an NLS. However, deletion of both the SAP and the DCR domain restores a nuclear localization, although the mutated protein does no longer appear to be associated with chromatin.
Interestingly, there is no clear relationship between the subcellular localization and the phenotypic effect displayed by the individual mutants (Fig. 7C) . While except for the DSAPDDCR double mutant the nuclear localization seems to depend on an intact SAP domain, the phenotypic effect observed in RNA injection studies clearly requires the presence of the C-terminally extended DCR domain being independent of nuclear or cytosolic localization. However, this finding is complicated by the fact that neither the wild type protein is exclusively localised in the nucleus nor the mutants lacking the SAP domain are exclusively located in the cytosol. 
2.9.
XDppa2/4 gain and loss of function mutants induce apoptosis
Next we investigated whether the lethality of embryos observed in gain and loss of function experiments is associated with apoptosis or simply the result of necrosis following aberrant gastrulation and neurulation movements. It was recently reported that mDppa4 overexpression suppressed cell differentiation and caused massive cell death in differentiating ES cells (Masaki et al., 2007) . To analyze apoptosis, we have performed TUNEL assays on embryos at stage 11.5 and at stage 18, which had previously been injected at the 2-cell stage with either XDppaMO or XDppa2/4, mDppa2 and mDppa4 RNA (Fig. 8A ). We observed a high level of apoptotic cells during gastrulation after overexpression of XDppa2/4 and mDppa4, as compared to uninjected control or ctrlMO injected embryos. Neither mDppa2 injected nor XDppaMO injected embryos exhibited increased numbers of apoptotic cells during gastrulation. However, this situation changed during neurulation, when not only embryos injected with XDppa2/4 or mDppa4 RNA showed even higher numbers of apoptotic cells, but also the XDppaMO injected embryos exhibited a progressive increase in apoptosis. Compared to the controls, apoptosis increased only slightly in embryos injected with mDppa2. Apoptosis can be induced by different types of caspases. We used a luminescence based assay for specific substrates to determine the activity of two initiator caspases. Caspase 8 mediates the extrinsic receptor-mediated apoptosis and caspase 9 mediates the stress-induced intrinsic apoptosis. In addition the activity of effector caspases 3/7 were tested. Embryos injected with XDppa2/4, mDppa2 or mDppa4 RNA and XDppaMO were analyzed at stages 11.5 and 18 (Fig. 8B) . At stage 11.5, no increased caspase activity was found for the two initiator caspases 8 and 9 in all injected embryos. However, the activity of the effector caspases 3/7 was enhanced subsequent to both XDppa2/4 (3.4-fold) and mDppa4 overexpression (2.0-fold). At stage 18, the activities of caspases 8 and 9 were again not different from controls, whereas caspases 3/7 showed 3.3-fold higher levels of activity following XDppa2/4 and 2.6-fold higher levels following mDppa4 overexpression. Moreover, we observed a 1.8-fold higher activity of caspases 3/7 in the XDppa2/4 loss of function embryos. In support of the results from the TUNEL assays, injection of mDppa2 RNA triggered only a very weak increase of caspase 3/7 activity. Taken together, our experiments demonstrate that overexpression as well as functional knockdown of XDppa2/4 lead to an increased rate of apoptosis accompanied by activation of effector caspases 3/7.
Discussion
Dppa2/4 genes are not confined to genomes of higher vertebrates
Mammalian developmental pluripotency associated genes are actively transcribed in pluripotent cells, like cells of the pre-implantation embryo, the epiblast and the germ line, but expression is absent from somatic tissues (Bortvin et al., 2003) . While these genes have been so far investigated exclusively in eutherians, here we report for the first time identification and characterisation of a Dppa2/4-like gene in the lower vertebrates, X. tropicalis and X. laevis.
Dppa2, Dppa3 and Dppa4 contain a SAP domain (Aravind and Koonin, 2000) . This structural motif enabled us to identify putative SAP domain-containing members of the Dppa family in the amphibians X. tropicalis and X. laevis, in the marsupials short-tail opossum and Australian brush tail possum as well as in the reptile Anolis carolinensis. Moreover, the close structural relationship to Dppa2 and Dppa4 is documented further by the common presence of an additional conserved module located at the C-terminus (Maldonado-Saldivia et al., 2007) , which we here designate as DCR (Dppa2/4 conserved region).
A functional homology between XDppa2/4 and mDppa2 or mDppa4 was first deduced by the observation of similar phenotypes in gain of function experiments. Noteworthy, we found only a few differences when comparing the effects of mDppa2 and mDppa4 overexpression on target gene regulation. Since some functional differences for ES cell differentiation have already been reported (Masaki et al., 2007) , we suppose that mDppa2 and mDppa4 have functionally diverged during evolution, despite their similar expression patterns and sequences (Maldonado-Saldivia et al., 2007) . Furthermore, it has been shown in cell culture that overexpression of mDppa4 leads to increased cell death, mDppa2 on the other hand does not (Masaki et al. 2007 ). We here show that ectopic expression of XDppa2/4 as well as mDppa4 but not mDppa2 can induce apoptosis during early Xenopus development.
To further demonstrate the functional homology between XDppa2/4 and its mammalian counterparts, we have shown that the XDppa2/4 loss of function phenotype during gastrulation can be rescued by mDppa2 RNA. Embryos co-injected with XDppaMO and mDppa2 develop normally until the end of neurulation, although they die later on. Death could Fig. 8 -Analysis of apoptosis and determination of caspase activities. (A) Uninjected embryos or embryos injected at the 2-cell stage with 50 ng ctrlMO, 50 ng XDppaMO, 400 pg XDppa2/4, 800 pg mDppa2 or 100 pg mDppa4 were harvested at stage 11.5 or at stage 18 and subjected to TUNEL assays or (B) analyzed for the activities of the two initiator caspases 8 and 9 as well as for the two effector caspases 3/7. Embryos were homogenized and incubated with specific substrates. Chemoluminiscence of activated substrates was measured. The values in histograms are presented as relative light units normalized to uninjected embryos.
neither be prevented by co-injections of mDppa4 RNA nor by combinations of mDppa2 and mDppa4 RNA. Therefore, mDppa2 can functionally replace XDppa2/4 during gastrulation and neurulation, but XDppa2/4 appears to perform additional functions that can neither be substituted by mDppa2 nor by mDppa4.
3.2.
XDppa2/4 is required for embryogenesis Dppa genes are defined by their restricted, pluripotency associated expression pattern (Bortvin et al., 2003; Maldonado-Saldivia et al., 2007) . RT-PCR and whole mount in situ hybridisation revealed that the level of maternal XDppa2/4 transcripts decreases after the blastula stage, when the differentiation program is initiated. XDppa2/4 is expressed in cells with a pluripotent character including oocytes and early cleavage embryos, but not in somatic tissues. Therefore, XDppa2/4 behaves in expression like a member of the developmental pluripotency associated gene family.
The role of Dppa2 and Dppa4 in murine ES cells for the maintenance of pluripotency and self-renewal has been studied by overexpression and by functional knockdown (Ivanova et al., 2006; Masaki et al., 2007) . While both studies agree in that Dppa4 is not required for self-renewal, conflicting results are reported for the role of Dppa4 in ES cell differentiation. Dppa4 depletion is reported to result in the differentiation of ES cells into primitive ectoderm even in the presence of LIF (Masaki et al., 2007) . However, induced differentiation of ES cells by shRNA was not supported by another study (Ivanova et al., 2006) . A recent report using a knockout strategy strongly suggests that both, mDppa2 and mDppa4 are dispensable for embryonic stem cell identity and germ cell development, but essential for embryogenesis, as Dppa4(À/ À) embryos were subject to late embryonic/peri-natal death (Madan et al., 2009) . Our results regarding the functional knockdown of XDppa2/4 in Xenopus embryonic development are similar. XDppa2/4 loss of function embryos started to die when controls enter tailbud stages. To date, the reason for their mortality is unknown, even more in light of the findings that embryos die at a time point when XDppa2/4 expression has already ceased. A plausible explanation might be that this factor also causes epigenetic modifications, as it has recently been suggested for mDppa3 (Nakamura et al., 2007) . Noteworthy, mDppa3 also contains a SAP domain presumably mediating protein function. This DNA-binding SAP domain could perform a specific role in chromosomal reorganization. As previously reported for mDppa4 (Masaki et al., 2007) , we demonstrate here that XDppa2/4 is associated with chromatin and that this association requires the SAP domain.
To investigate the loss of function and gain of function phenotypes in more detail, we analysed the expression of a set of marker genes known to be involved in the induction of germ layers or to be closely associated with specific developmental fates. At stage 11, the knockdown is accompanied by an increase of ventral mesodermal markers, the neural inducing factor Xnr3, which is known to antagonize BMP activity (Glinka et al., 1996) , and mesendodermal inducers like On the other hand, this interpretation is not in line with the observed downregulation of Xbra and the upregulation of Xnrs in case of gain of function. Taken together these results suggest that XDppa function cannot simply be assigned to the establishment or maintenance of a pluripotent state and prevention of differentiation. Rather, Dppa expression appears to affect embryonic gene cascades further downstream, and thus may be required for regulating differentiation and patterning events during early embryogenesis.
3.3.
XDppa2/4 function during gastrulation does not require the SAP domain, but the SAP domain is indispensable for prevention of embryonic death
The mDppa4 gene encodes two splice variants. The smaller transcript is predicted to encode a protein lacking the SAP domain (Maldonado-Saldivia et al., 2007) . When tested in transfection experiments with recombinant expression vectors, the isoform containing the SAP domain has a nuclear and the isoform lacking the SAP domain a cytosolic localization (Madan et al., 2009 ). This subcellular distribution pattern correlates with our observation that transfection of HeLa cells with XDppa-EGFP led to a nuclear and transfection with DSAP led to a predominantly cytosolic localization. In contrast, the DDCR mutant revealed a nuclear distribution. Surprisingly, overexpression of the DSAP mutant resulted in a phenotype identical to that of XDppa2/4, whereas overexpression of the DDCR mutant resulted in normal embryos. Deletion of the first 65 amino acids including the SAP domain in the mutant aa66-240 or deletion of the N-teminal part (aa1-19) in front of the SAP domain revealed that neither the N-terminus nor the SAP domain is necessary for the observed gastrulation phenotype. It is also important to note, that this gain of function phenotype did not require a nuclear localization. While DNterm was localised in the nucleus, the DSAP and the aa66-240 mutants showed cytosolic localization. However, all constructs with deletion of the DCR domain showed normal blastopore closure and neurulation independent of their nuclear localization. In conclusion, these results demonstrate that the DCR domain is necessary to generate a phenotypic effect. However, injections of the DCR domain alone and in combination with the SAP domain revealed that the DCR domain alone is not sufficient to induce an effect but requires parts of the C-terminal region. Furthermore, the loss of function phenotype during gastrulation is also not caused by the lack of the SAP domain. The defect of blastopore closure after functional knockdown during gastrulation is not only rescued by overexpression of XDppa2/4 but also by the DSAP mutant. However, since the DSAP mutant cannot prevent the death of embryos at the end of neurulation, it is reasonable to assume that the SAP domain is required for normal development at later embryonic stages. This is probably achieved by epigenetic programming events during early stages, since XDppa2/4 transcripts disappear by the end of gastrulation. One might query, why mDppa2 containing a SAP domain is not sufficient to rescue the mortality effect. We assume that this failure is due to the evolutionary distance and to the high level of divergence between the mouse and Xenopus SAP domains.
We finally have investigated the structural identity of the C-terminally extended DCR domain. Protein BLAST analyses demonstrated obvious similarities to the pleckstrin homology (PH) domain of rat Plekhb1 (Andrews et al., 2000) (Fig. S3) . The PH domain, originally identified as a stretch of 100-120 aa in pleckstrin (Haslam et al., 1993) , is found in many eukaryotic proteins with diverse functions in cytosol and nucleus (Shaw, 1993) . PH domains share a common structure of seven bstrands, which form two antiparallel b-sheets, followed by a C-terminal a-helix (Riddihough, 1994; Lemmon et al., 1996; Isakoff et al., 1998) . It is important to note that in Dppa2/4 proteins the consensus sequence for the PH domain expands over the DCR domain towards the C-terminal region (Fig. S3) . This observation might explain the lack of phenotype after overexpression of the DCR domain alone and the fact that the rescue of the XDppa2/4 knockdown during neurulation can only be achieved by mDppa2 but not mDppa4, which lacks a corresponding C-terminal extension (see Fig. 1 ). However, further experiments are needed to unveil the extent of the proposed relationship between the DCR/C-terminal region of XDppa2/4 and the PH domain.
4.
Materials and methods
Database analyses and alignments
The following programs were used for EST, protein and comparative genomic analyses of Dppa homologues and for multiple sequence alignments: http://www.ncbi.nlm.nih.-gov/blast, http://www.ensembl.org/index.html, and http:// www.ebi.ac.uk/Tools/clustalw.
Culturing embryos
Embryos were obtained by in vitro fertilization. They were cultured in 0.1· MBSH (1· MBSH: 88 mM NaCl, 2.4 mM NaH-CO 3 , 1 mM KCl, 0.82 mM MgSO 4 , 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 10 mM HEPES, pH 7.4) until desired stages, when they were collected for whole mount in situ hybridizations or preparation of RNA.
4.3.
Morpholino oligonucleotides, cloning of plasmids and in vitro transcription of RNA 
Morpholino binding analyses in vitro and in vivo
The binding efficiency of XDppa2/4MO was tested in vitro with TNT Ò T7/SP6 Coupled Reticulocyte Lysate System (Promega) by using 0.5 lg plasmid and 10 ng of morpholino, according to the manufactures protocol. The efficiency of XDppaMO was tested in vivo by co-injection with XDppa2/4-EGFP RNA as compared to the injection of XDppa2/4-EGFP RNA alone or together with ctrlMO. Each 10 embryos were collected when control siblings reached stage 11.5, homogenized in 200 ll of lysis buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, 1% NP-40, protease inhibitor cocktail (Sigma)) and proteins were precipitated at 4°C. The samples were boiled in 1· Laemmli buffer (62.5 mM Tris, pH 6.8, 10% glycerol, 2.35% SDS, 0.001% bromphenol blue, 100 mM DTT, 1 mM EDTA) and subjected to electrophoresis and Western blotting. Signals were detected using the ECL Advance Western Blotting Detection Kit (Amersham) following the manufacturer's protocol. The first antibody, rabbit anti-GFP (Santa Cruz), was used at 1:10,000 and the second, goat anti-rabbit IgG-peroxidase (Amersham), at 1:10,000.
4.5.
Gene expression analysis by real time RT-PCR and by whole mount in situ hybridisation QiaZol (Qiagen) was used to extract total RNA from embryos. RNA was submitted to DNase I treatment and purified by using the RNeasy kit (Qiagen). First strand cDNA was synthesized from 2 lg of total RNA with RevertAid TM First Strand cDNA Synthesis kit (Fermentas). The real time RT-PCR reactions were done according to the QuantiTect TM SYBR Green PCR handbook (Qiagen) in a total volume of 20 ll, containing 10 ll of the QuantiTect TM SYBR Green PCR Master Mix (Qiagen), 0.5 lM of each primer and 2 ll of 1:10 diluted template cDNA. The primers used and the cycling conditions are listed in Supplementary Table S1 . For negative controls, water and RTwere used instead of template cDNA. The crossing point in log-linear phase of amplification was quantified by using LightCycler TM software version 1.0 (Roche). Values were normalized to the expression level of reference gene H4 (histone4) included in each run. The expression of each gene was calculated relative to uninjected control embryos, in which gene expression was considered as basal level. Data are presented in histograms as relative units. Experiments were repeated at least tree times. Whole mount in situ hybridisations were done according to standard procedures (Harland, 1991) .
4.6.
Detection of apoptosis by assays of caspase activities or TUNEL
To investigate the activities of caspases, embryos were collected at stage 11.5 and subjected to Caspase 3/7, Caspase 8 and Caspase 9 Glo Assay kits (Promega) following the manufacturer's protocol and modifications as described (Boorse et al., 2006) . Each 10 embryos at stage 11.5 or stage 17, respectively, were homogenized in 200 ll PBS. Two independent experiments were carried out. The TUNEL was performed as previously described (Schuff et al., 2007) .
Cellular transfection and imaging
HeLa cells (ATCC CCL2) were grown at 37°C under 5% CO 2 in Dulbecco's Modified Eagle Medium (DMEM, Gibco) supplemented with 10% fetal calf serum (FCS). For imaging, cells were cultured on chambered cover slips (Nunc) at a density of 10 5 cells per cm 
